BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 16890865)

  • 61. In vitro evaluation of the antimicrobial efficacy of a new silver-triclosan vs a silver collagen-coated polyester vascular graft against methicillin-resistant Staphylococcus aureus.
    Ricco JB; Assadian A; Schneider F; Assadian O
    J Vasc Surg; 2012 Mar; 55(3):823-9. PubMed ID: 22079169
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Aortoiliac endarterectomy: a lost art?
    Connolly JE; Price T
    Ann Vasc Surg; 2006 Jan; 20(1):56-62. PubMed ID: 16378154
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Femoral incision morbidity following endovascular aortic aneurysm repair.
    Slappy AL; Hakaim AG; Oldenburg WA; Paz-Fumagalli R; McKinney JM
    Vasc Endovascular Surg; 2003; 37(2):105-9. PubMed ID: 12669141
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cryopreserved homograft and autologous deep vein replacement for infrarenal aorto and iliaco-femoral graft infection: early and late results.
    Bíró G; Szeberin Z; Nemes A; Acsády G
    J Cardiovasc Surg (Torino); 2011 Apr; 52(2):169-76. PubMed ID: 21464818
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Aortobifemoral grafting: factors influencing long-term results.
    Davidovic L; Vasic D; Maksimovic R; Kostic D; Markovic D; Markovic M
    Vascular; 2004; 12(3):171-8. PubMed ID: 15586525
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prophylactic muscle flaps in vascular surgery.
    Fischer JP; Nelson JA; Mirzabeigi MN; Wang GJ; Foley PJ; Wu LC; Woo EY; Kanchwala S
    J Vasc Surg; 2012 Apr; 55(4):1081-6. PubMed ID: 22209610
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Patency rates of femorofemoral bypasses associated with endovascular aneurysm repair surpass those performed for occlusive disease.
    Lipsitz EC; Ohki T; Veith FJ; Rhee SJ; Gargiulo NJ; Suggs WD; Wain RA
    J Endovasc Ther; 2003 Dec; 10(6):1061-5. PubMed ID: 14723569
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A double bifurcated graft for abdominal aorta and bilateral iliac artery reconstruction.
    Akiyama K; Takazawa A; Hirota J; Yamanishi H; Akazawa T; Maeda T
    Surg Today; 1999; 29(4):313-6. PubMed ID: 10211560
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prosthetic bifurcation grafting in occlusive and aneurysmal aortoiliac disease--a follow-up study.
    Soisalon-Soininen S; Salo JA; Luosto R; Mattila S
    Vasa; 1993; 22(4):330-7. PubMed ID: 8310772
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Total laparoscopic bypass is safe and effective for aortoiliac occlusive disease.
    Ghammad K; Dupuis A; Amond L; D'Hont C; Wijtenburg E; Piette P; Remy P
    J Vasc Surg; 2015 Mar; 61(3):698-702. PubMed ID: 25720928
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Management of abdominal aortic prosthetic graft infection requiring emergent treatment.
    Mingoli A; Sapienza P; di Marzo L; Sgarzini G; Burchi C; Modini C; Cavallaro A
    Angiology; 1997 Jun; 48(6):491-5. PubMed ID: 9194534
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Early complications of femorofemoral crossover bypass grafts after aorta uni-iliac endovascular repair of abdominal aortic aneurysms.
    Walker SR; Braithwaite B; Tennant WG; MacSweeney ST; Wenham PW; Hopkinson BR
    J Vasc Surg; 1998 Oct; 28(4):647-50. PubMed ID: 9786259
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Results from the first in man german pilot study of the silver graft, a vascular graft impregnated with metallic silver.
    Zegelman M; Guenther G; Florek HJ; Orend KH; Zuehlke H; Liewald F; Storck M
    Vascular; 2009; 17(4):190-6. PubMed ID: 19698298
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Aortoiliac graft infection as a diagnostic and treatment problem].
    Gutowski P
    Ann Acad Med Stetin; 1998; Suppl 41():1-72. PubMed ID: 9766086
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In-situ revascularisation for patients with aortic graft infection: a single centre experience with silver coated polyester grafts.
    Batt M; Jean-Baptiste E; O'Connor S; Bouillanne PJ; Haudebourg P; Hassen-Khodja R; Declemy S; Farhad R
    Eur J Vasc Endovasc Surg; 2008 Aug; 36(2):182-188. PubMed ID: 18440252
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risk factors and outcomes for nosocomial infection after prosthetic vascular grafts.
    Fariñas MC; Campo A; Duran R; Sarralde JA; Nistal JF; Gutiérrez-Díez JF; Fariñas-Álvarez C
    J Vasc Surg; 2017 Nov; 66(5):1417-1426. PubMed ID: 28823865
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Use of the descending thoracic aorta as an inflow source in aortoiliac reconstruction: indications and long-term results.
    Criado E; Keagy BA
    Ann Vasc Surg; 1994 Jan; 8(1):38-47. PubMed ID: 8192998
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Systemic effects of collagen-impregnated aortoiliac Dacron vascular prostheses on platelet activation and fibrin formation.
    De Mol Van Otterloo JC; Van Bockel JH; Ponfoort ED; Briet E; Brommer EJ; Hermans J; Daha MR
    J Vasc Surg; 1991 Jul; 14(1):59-66. PubMed ID: 1829489
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Early results after peripheral vascular replacement with biosynthetic collagen prosthesis in cases of graft infection].
    Fellmer PT; Wiltberger G; Tautenhahn HM; Matia I; Krenzien F; Jonas S
    Zentralbl Chir; 2014 Oct; 139(5):546-51. PubMed ID: 23341133
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Graft infectivity of rifampin and silver-bonded polyester grafts to MRSA contamination.
    Schmacht D; Armstrong P; Johnson B; Pierre K; Back M; Honeyman A; Cuthbertson D; Bandyk D
    Vasc Endovascular Surg; 2005; 39(5):411-20. PubMed ID: 16193213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.